Profile of CD103 expression in T-cell neoplasms: Immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma

American Journal of Surgical Pathology

Volumn 38, Issue 11, 2014, Pages 1557-1570

  Morgan, Elizabeth A ^a   Pihan, German A ^b   Said, Jonathan W ^d   Yu, Hongbo ^c   Pinkus, Jack L ^a   Dorfman, David M ^a   Rodig, Scott J ^a   Pinkus, Geraldine S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

CD103; Enteropathy associated T cell lymphoma; Immunohistochemistry; Paraffin; T cell neoplasm

Indexed keywords

ALPHA E INTEGRINS; ALPHA INTEGRIN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN; TUMOR MARKER;

CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC USE; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FROZEN SECTION; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; T CELL LEUKEMIA; T CELL LYMPHOMA; UNITED STATES;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FROZEN SECTIONS; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; LEUKEMIA, T-CELL; LYMPHOMA, T-CELL; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84914813307     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000296     Document Type: Article

References (60)

1. Cerf-Bensussan N, Jarry A, Brousse N, et al. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol. 1987;17:1279-1285.
2. Shaw SK, Cepek KL, Murphy EA, et al. Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J Biol Chem. 1994;269:6016-6025.
3. Visser L, Shaw A, Slupsky J, et al. Monoclonal antibodies reactive with hairy cell leukemia. Blood. 1989;74:320-325.
4. Schwarting R, Dienemann D, Kruschwitz M, et al. Specificities of monoclonal antibodies B-ly7 and HML-1 are identical. Blood. 1990;75:320-321.
5. Flenghi L, Spinozzi F, Stein H, et al. LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia. Br J Haematol. 1990;76:451-459.
6. Kruschwitz M, Fritzsche G, Schwarting R, et al. Ber-ACT8: new monoclonal antibody to the mucosa lymphocyte antigen. J Clin Pathol. 1991;44:636-645.
7. Cepek KL, Wong DA, Brenner MB, et al. AS7/8.4. CD103 (alphaE) cluster report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, et al, eds. Leukocyte Typing V: White cell Differentiation Antigens. Proceedings of the Fifth International Workshop and Conference Held in Boston, USA 3-7 November, 1993. Oxford: Oxford University Press; 1995:1666-1667.
8. Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature. 1994;372:190-193.
9. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998;114:471-481.
10. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205:255-274.
11. Moller P, Mielke B, Moldenhauer G. Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas. Am J Pathol. 1990;136:509-512.
12. Hingorani M, Metz D, Lightman SL. Characterisation of the normal conjunctival leukocyte population. Exp Eye Res. 1997;64:905-912.
13. Woodberry T, Suscovich TJ, Henry LM, et al. Alpha E beta 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population. J Immunol. 2005;175:4355-4362.
14. Morgan EA, Yu H, Pinkus JL, et al. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody. Am J Clin Pathol. 2013;139:220-230.
15. - regulatory T cells. Proc Natl Acad Sci USA. 2002;99:13031-13036.
16. + T cells. J Immunol. 2006;177:2775-2783.
17. + dendritic cells display unique functional properties that are conserved between mice and humans. J ExpMed. 2008;205:2139-2149.
18. Visser L, Dabbagh L, Poppema S. Reactivity of monoclonal antibody B-ly7 with a subset of activated T cells and T-cell lymphomas. Hematol Pathol. 1992;6:37-42.
19. Spencer J, Cerf-Bensussan N, Jarry A, et al. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol. 1988;132:1-5.
20. Stein H, Dienemann D, Sperling M, et al. Identification of aTcell lymphoma category derived from intestinal-mucosa-associated T cells. Lancet. 1988;2:1053-1054.
21. Pallesen G, Hamilton-Dutoit SJ. Monoclonal antibody (HML-1) labelling of T-cell lymphomas. Lancet. 1989;1:223-224.
22. Brousse N, Jarry A, Peuchmaur M, et al. Monoclonal antibody (HML-1) reactivity of T-cell lymphomas. Lancet. 1989;2:1107-1108.
23. + T cells. Blood. 1990;76:959-964.
24. Falini B, Flenghi L, Fagioli M, et al. Expression of the intestinal Tlymphocyte associated molecule HML-1: analysis of 75 non-Hodgkin's lymphomas and description of the first HML-1 positive T-lymphoblastic tumour. Histopathology. 1991;18:421-426.
25. Sperling M, Kaudewitz P, Braun-Falco O, et al. Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol. 1989;134:955-960.
26. Isaacson PG, Chott A, Ott G, et al. Enteropathy-associated T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid TIssues. Lyon: IARC; 2008:289-291.
27. Muller-Hermelink HK, Delabie J, Ko YH, et al. T-cell lymphoma of the small intestine. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010:112-114.
28. Swerdlow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
29. Pallesen G, Hamilton-Dutoit SJ. Specificity of monoclonal antibody HML-1. Lancet. 1990;335:537.
30. Moldenhauer G, Mielke B, Dorken B, et al. Identity of HML-1 antigen on intestinal intraepithelial T cells and of B-ly7 antigen on hairy cell leukaemia. Scand J Immunol. 1990;32:77-82.
31. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141:1361-1371.
32. Kitajima S, Tokunaga M, Goto M, et al. Monoclonal antibody HML-1 reactivity with adult T-cell leukaemia/lymphoma and other lymphomas. Histopathology. 1994;25:229-236.
33. Simonitsch I, Volc-Platzer B, Mosberger I, et al. Expression of monoclonal antibody HML-1-defined alpha E beta 7 integrin in cutaneous T cell lymphoma. Am J Pathol. 1994;145:1148-1158.
34. Schmitt-Graff A, Daum S, Hummel M, et al. Presence of clonal Tcell receptor gene rearrangements provides evidence of widespread intramucosal intestinal T-cell lymphoma. Z Gastroenterol. 1996;34:680-685.
35. Dietz SB, Whitaker-Menezes D, Lessin SR. The role of alpha E beta 7 integrin (CD103) and E-cadherin in epidermotropism in cutaneous T-cell lymphoma. J Cutan Pathol. 1996;23:312-318.
36. Shimada-Hiratsuka M, Fukayama M, Hayashi Y, et al. Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer. 1997;80:292-303.
37. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723-1731.
38. - T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998;153:1483-1490.
39. Carbonnel F, D'Almagne H, Lavergne A, et al. The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut. 1999;45:662-667.
40. Foss HD, Schmitt-Graff A, Daum S, et al. Origin of primary gastric T-cell lymphomas from intraepithelial T-lymphocytes: report of two cases. Histopathology. 1999;34:9-15.
41. Barth TF, Leithauser F, Dohner H, et al. Primary gastric apoptosisrich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules. Virchows Arch. 2000;436:357-364.
42. Katoh A, Ohshima K, Kanda M, et al. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leuk Lymphoma. 2000;39:97-111.
43. Delgado J, Bustos JG, Jimenez MC, et al. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders? Leuk Lymphoma. 2002;43:2331-2334.
44. Hatano B, Ohshima K, Katoh A, et al. Non-HTLV-1-associated primary gastric T-cell lymphomas show cytotoxic activity: clinicopathological, immunohistochemical characteristics and TIA-1 expression in 31 cases. Histopathology. 2002;41:421-436.
45. Niitsu N, Nakamine H, Kohri M, et al. Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature. Ann Hematol. 2003;82:197-202.
46. Okada M, Maeda K, Suzumiya J, et al. Primary colorectal T-cell lymphoma. J Gastroenterol. 2003;38:376-384.
47. Yuan CM, Stein S, Glick JH, et al. Natural killer-like T-cell lymphoma of the small intestine with a distinct immunophenotype and lack of association with gluten-sensitive enteropathy. Arch Pathol Lab Med. 2003;127:e142-e146.
48. Iwamizu-Watanabe S, Yamashita Y, Yatabe Y, et al. Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas. Pathol Int. 2004;54:503-509.
49. Muram-Zborovski T, Loeb D, Sun T. Primary intestinal intraepithelial natural killer-like T-cell lymphoma: case report of a distinct clinicopathologic entity. Arch Pathol Lab Med. 2009;133:133-137.
50. Takeshita M, Nakamura S, Kikuma K, et al. Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan. Histopathology. 2011;58:395-407.
51. Wilson AL, Swerdlow SH, Przybylski GK, et al. Intestinal gammadelta T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol. 2013;44:1131-1145.
52. Otsuka M, Hanada S, Utsunomiya A, et al. Expression of the intestinal T-lymphocyte-associated-molecule recognized by the HML-1 antibody on mononuclear cells from HTLV-I-infected subjects. Am J Hematol. 1995;50:1-8.
53. Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132:1902-1911.
54. Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148-155.
55. Chan JK, Chan AC, Cheuk W, et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol. 2011;35:1557-1569.
56. Ko YH, Karnan S, Kim KM, et al. Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomic hybridization study. Hum Pathol. 2010;41:1231-1237.
57. Garcia-Herrera A, Song JY, Chuang SS, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35:1214-1225.
58. Tan SY, Nakamura S, Tan HC, et al. Diagnosis of type II enteropathy-associated T-cell lymphoma should be limited to EBER-cases. Am J Hematol. 2012;87:E129-E130.
59. Chuang SS, Liao YL, Liu H, et al. The phenotype of intraepithelial lymphocytes in Taiwanese enteropathy-associated T-cell lymphoma is distinct from that of the West. Histopathology. 2008;53:234-236.
60. Tan SY, Chuang SS, Tang T, et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia. 2013;27:1688-1696.